Skip to the page

Data / Form D filings / NeuroEM Therapeutics, Inc.

NeuroEM Therapeutics, Inc.: Form D filings

NeuroEM Therapeutics, Inc., a health care company in Tampa, FL, filed 2 Form D notices with the SEC between 2024 and 2025. The latest, on April 23, 2025, reports $1.9 million sold of a $6.5 million offering to 23 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
501 E KENNEDY BOULEVARD, SUITE 650, Tampa, FL, 33602
Phone
(727) 252-6120
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2026871

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 23, 2025New notice$6,480,840$1,946,539$4,534,30123Apr 9, 2025sec.gov
Jun 17, 2024New notice$500,000$360,000$140,00012May 31, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Chuck PapageorgiouExecutive Officer, Director
Mitch LarimoreDirector
Jonathan GordonDirector

Other health care companies in Florida that filed recently

Every Form D from the week of Apr 21, 2025 · All recent filings in Florida · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what NeuroEM Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.